Finally, these results were corroborated using mice deficient in Arginase 1 expression in Tie2 positive cells demonstrating that the anti-tumor efficacy of the PD-1 blockade was not improved when arginase 1 was absent. The gene discussed is PDCD1; the disease is neoplasm.